0001178913-20-001769.txt : 20200610 0001178913-20-001769.hdr.sgml : 20200610 20200610080020 ACCESSION NUMBER: 0001178913-20-001769 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200610 DATE AS OF CHANGE: 20200610 EFFECTIVENESS DATE: 20200610 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioLineRx Ltd. CENTRAL INDEX KEY: 0001498403 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-368607 FILM NUMBER: 20953534 BUSINESS ADDRESS: STREET 1: 2 HAMA-AYAN STREET STREET 2: MODI-IN TECHNOLOGY PARK CITY: MODI-IN STATE: L3 ZIP: 7177871 BUSINESS PHONE: 972-2-548-9100 MAIL ADDRESS: STREET 1: 2 HAMA-AYAN STREET STREET 2: MODI-IN TECHNOLOGY PARK CITY: MODI-IN STATE: L3 ZIP: 7177871 FORMER COMPANY: FORMER CONFORMED NAME: BioLineRX, Ltd. DATE OF NAME CHANGE: 20100805 D 1 primary_doc.xml X0708 D LIVE 0001498403 BioLineRx Ltd. 2 HAMA'AYAN STREET MODI'IN L3 ISRAEL 7177871 972-8-642-9100 ISRAEL None BioLineRX, Ltd. Corporation true Aharon Schwartz c/o BioLineRx Ltd. 2 HaMa'ayan Street Modi'in L3 ISRAEL 7177871 Director Michael J. Anghel c/o BioLineRx Ltd. 2 HaMa'ayan Street Modi'in L3 ISRAEL 7177871 Director Nurit Benjamini c/o BioLineRx Ltd. 2 HaMa'ayan Street Modi'in L3 ISRAEL 7177871 Director Barbara Jean Bormann c/o BioLineRx Ltd. 2 HaMa'ayan Street Modi'in L3 ISRAEL 7177871 Director Raphael Hofstein c/o BioLineRx Ltd. 2 HaMa'ayan Street Modi'in L3 ISRAEL 7177871 Director Avraham Molcho c/o BioLineRx Ltd. 2 HaMa'ayan Street Modi'in L3 ISRAEL 7177871 Director Sandra Panem c/o BioLineRx Ltd. 2 HaMa'ayan Street Modi'in L3 ISRAEL 7177871 Director Philip A. Serlin c/o BioLineRx Ltd. 2 HaMa'ayan Street Modi'in L3 ISRAEL 7177871 Executive Officer Mali Zeevi c/o BioLineRx Ltd. 2 HaMa'ayan Street Modi'in L3 ISRAEL 7177871 Executive Officer Ella Sorani c/o BioLineRx Ltd. 2 HaMa'ayan Street Modi'in L3 ISRAEL 7177871 Executive Officer Abi Vainstein-Haras c/o BioLineRx Ltd. 2 HaMa'ayan Street Modi'in L3 ISRAEL 7177871 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2020-05-31 false true true false 0 H.C. Wainwright & Co., LLC 375 None None 430 PARK AVENUE 3RD FLOOR NEW YORK NY NEW YORK 10022 IL ILLINOIS NJ NEW JERSEY NY NEW YORK false 4393000 4393000 0 The warrants and shares underlying the warrants, the subject matter of this Form D were issued in connection with an offering of (i) 2,510,286 ADSs issued in a registered direct offering, and (ii) unregistered warrants to purchase 2,510,286 ADSs. false 5 307510 0 H.C. Wainwright is also entitled to 1.0% of the gross proceeds as management fee, a $25,000 non-accountable expense reimbursement, a $35,000 accountable expense allowance and warrants to purchase 125,514 ADSs exercisable at $2.1875 per ADS for 2.5 years. 0 Issuer expects to use proceeds from the offering for general corporate purposes, which may include but are not limited to working capital, funding clinical trials and payment of salaries and related expenses to the named executive officers. false BioLineRx Ltd. /s/ Mali Zeevi Mali Zeevi Chief Financial Officer 2020-06-10